It was great to hear from our Senior Vice President of Early Development, Glenn Short, at the @BostonDOT conference this week.
Glenn’s presentation on AI-assisted/structure-based drug design is just one example of how, at atai, we are leveraging cutting-edge technology to accelerate drug discovery in order to bring the next generation of mental health treatments to patients as efficiently and effectively as possible.
#mentalhealth #BostonDOT23 #psychedelics #AI